HOOKIPA PHARMA INC. Additional Paid in Capital
HOOKIPA PHARMA INC. had Additional Paid in Capital of $468.71 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2025-05-15
- 2025-03-31: Additional Paid in Capital $468.71M.
- 2024-12-31: Additional Paid in Capital $469.06M.
- 2024-09-30: Additional Paid in Capital $468.20M.
- 2024-06-30: Additional Paid in Capital $467.26M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2025-03-31 | $468.71M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $469.06M 10-Q · filed 2025-05-15 | |
| 2024-09-30 | $468.20M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $467.26M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $466.79M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $467.05M 10-K · filed 2025-02-28 | $467.04M 10-K · filed 2024-03-22 |
| 2023-09-30 | $445.51M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $444.94M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $398.01M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $397.35M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $396.35M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $395.31M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $393.93M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $317.13M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $315.39M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $313.67M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $310.93M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $309.29M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $231.99M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $229.83M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $227.67M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $225.57M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $223.45M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $221.58M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $3.71M 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $3.33M 10-K · filed 2020-03-19 |